Pinned Tweet
COLOR III trial=Extensive Quality Assurance with Central review:
Indication: 💿MRI
Surgical technique: 📹Operation 🎞️
Pathology: 📷Specimen
Local recurrence: MRI 💿3 years FU
all 🔗linked to clinical outocme in online 🔐💻platform.
#TaTME #TaTME_month #colorectalresearch
Exciting news! The COLOR3 trial has just reached a major milestone. We have successfully randomised 1000 patients! We would like to thank all participating centres for their great efforts. We hope to reach final enrolment in December or January 2024! Let's keep up the good work!
COLOR trial update: we have reached 900 randomized patients! Thanks to all centers for their hard work, we had a very fruitful year and are close to the full sample size of 1104 patients. Lets finish in 2023! #tatme #rectalsurgery
🏆Today our top 1 including center Friendship Hospital Beijing included their 100th COLOR patient! Congratulations and thank you for your fantastic work! Special thanks to @Hongweiyao #TaTME #rectalsurgery #color3china
COLOR III retweeted
“Surgeons with experience in TaTME are not advised against performing TaTME in patients with low rectal cancer …”. link.springer.com/article/10…
Please join us at the international COLOR III meeting on the 3rd of March 2022 at 13:00hr (Amsterdam Time) with our collaborators from all over the world! We will discuss the progress of the COLOR III trial and interesting topics regarding rectal surgery #TaTME #rectalsurgery
COLOR III retweeted
Looking for to the 3rd PelvEx meeting in the beautiful city Amsterdam - See PelvEx2022.org for details @PelvExGroup @JurriaanTuynman @ P Burger, J Tolenaar and A Aalbers @des_winter @mekelly123 @escp_tweets @ASCRS_1
📈Trial update 6.1.22
We have reached #700! Total registered 773, randomized 705. Top including centers of Dec = Friendship Hospital Beijing (8), Gelderse Vallei (3), NCCH-East Japan (3), FHA-Chongqing (3).The accrual of Dec = 23. Big🙏to all! #tatme @colinsietses @AntoniodeLacy
COLOR III retweeted
In November's issue of BJS: Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer academic.oup.com/bjs/article… @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs
COLOR III retweeted
Replying to @SWexner @ParisTekkis @JNCCN @taTMEsurgery @taTME_education @UStaTMEtrial @patsyllamd @SamAtallahMD @TAMISYoda @TAMISsurgeon @caycedomarula @Schadi_CRS
Thank you @SWexner for the excellent editorial. More data to come from @UStaTMEtrial @COLOR3_trial hopefully soon in support of safe @taTMEsurgery. Thanks to all collaborative surgeons who contribute to TaTME registry
🚨Accrual update 26 nov '21
Total patients registered 747
Randomized 680
Some excl by second read of MRI /M+
👏Participating centres 🙏 for efforts so far, please keep including patients! #TaTME
@EAES_eu #WCES2021
@AntoniodeLacy @colinsietses @FelixAigner2 @SvanOostendorp
📈Study update #TaTME: #649 randomized pts of the full sample size of #1104! Top 3 including centers: 1. Beijing Friendship Hospital China @yaohongwei, 2. Gelderse Vallei NL @colinsietses and Shanghai Renji Hospital China @QingXu. Big🙏to all collaborators for their great work
Today the virtual 16th Annual Scientific Conference of the European Society of Colorproctology @escp_tweets starts. On Friday Sept 24th we will present the COLOR III trial at the 'New Trial Forum' (time: 8.30AM till 09.45AM) to invite even more centers to join the COLOR3 group!
COLOR III retweeted
Last Friday 2/7/‘21 - #PhD defense @amsterdamumc @VUamsterdam
“Minimally invasive treatment strategies for rectal cancer”
Thank to my supervisors, coauthors and collaborators over the world
#SoMe4Surgery #TaTME #TAMIS #colorectalsurgery
@CRS_trials @COLOR3_trial @NlWcp @me4_so
COLOR III retweeted
Congratulations Dr. @borjadelacy on your incredibly impressive defense today of your PhD thesis @UniBarcelona and the very well deserved unanimous recommendation of the tribunal of your being awarded with your well earned PhD degree @BalibreaJose @AntoniodeLacy @AISChannel
COLOR III retweeted
Looking forward!
Tune in to @CleClinicMD @CleveClinicFL @AISChannel #InnovationsInSurgery on 6/4/21, to hear @Swexner and @AntoniodeLacy discuss, “Transanal Total Mesorectal Excision: Should We Continue or Abandon It?”. https://teapawt.net/t.co/5Sa2L7KRS4 pwd is innovations @AISChannel @hospitalclinic
COLOR III retweeted
Noticed and 👏, addressed in the discussion with some possible explanation. Nevertheless, after 🇳🇴+🇳🇱alarm on #TaTME not coming from tertiary referral centers, more external audits and robust trial data needed.
Quick📸 series from expert centers👉excellent!
#colorectalsurgery
COLOR III retweeted
The learning curve of TaTME for #rectalcancer is associated with local recurrence
>12% during the learning curve
⬇️ to > 3% with experience
@JurriaanTuynman @SvanOostendorp
@colinsietses @EAES_eu @escp_tweets @NlWcp
#openaccess @ColorectalDis
onlinelibrary.wiley.com/shar…




























